Abstract:2-alkyl-6-bromo-3,1-benzoxazine-4-one (2) is synthesized by treating p-Bromoanthranilic acid and Acetylechoride or Benzoylchloride. Reaction of 2-alkyl-6-bromo-3,1-benzoxazine-4-one (2). with hydrazinehydrate furnish the corresponding 3-Amino-2-methyl-6-bromoquinazoline-4(3H)-one (3) which on reaction with benzaldehyde afford N,N -arylidene derivative (4). Reaction of 4 with various diazonium salts yields 6-bromo-2-alkyl/aryl-3{[phenyl(phenyldiazenyl)methylene]amino}quinazolin-4(3H)-one .
Introduction
Quinazoline nucleus possessed the potent pharmacodynamic nucleus. In addition several quinazoline derivatives posses diverse biological activities Viz. anticonvulsant 1 , hyponotics 2 , antiinflammatory 3, 4 , diuretics antihypertensive 5, 6, 7 , antituberculor etc. quinazoline system posses variable sites at 2 and 3 positions substituted by various hetrocyclic moieties afford the potent anticonvulsant agent. Furthermore SAR study of different quinazolinone derivatives have revealed that the substitution at 3-position has significant role on hypotensive activity.
Experimental
All the melting points were determined in open capillary and are uncorrected. The purity is checked by TLC. IR Spectras were recorded in KBr on shimatzu F.T. -IR 8300 spectrophotometer. Analytical data were also confirmed from its H -NMR Spectra.
The starting compound 2-alkyl/aryl-3-amino-6-bromo quinazolinone has been prepared according to known method 8, 9 .
3-amino-2-alkyl/aryl-6-bromoquinazoline-4(3H)-one 3 has been prepared by known method.
8,9

Synthesis of 6-bromo-2-alkyl/aryl-3{[(1E)-phenylmethylene]amino}quinazoline-4(3H)one 4:
3-Amino-2-alkyl/aryl-7-bromoquinazoline-4(3H)-one 3(0.01 mole) and benzaldehyde (0.01 mole) were refluxed in absolute ethanol (40ml) for 3 hrs. The excess solvent was then distilled off and the resulting solid washed with water, dried and recrystallized from ethanol. 
Synthesis of 6-bromo -2 -alkyl/aryl -3 {[phenyl (phenyldiazenyl) methylene] amino} quinazoline -4(3H) -one 5 :
Appropriate amine (0.02 Mole) in glacial Acetic acid (2ml) & HCl (1.5ml) was diazotised with NaNO 2 (0.2 g in 2 ml H 2 O) at 0-5 ˚C. The resultant diazoniumchloride solution was added with stirring to a solution of (4) (0.02 mole) in pyridine. (3 ml) in the cold. The reaction mixture. was left over night at ambient temperature. There after, it was poured into cold water (250 ml) with stirring when a dark coloured solid separated out. It was filtered, washed, repeatedly with water containing HCl and finally with water and recrystallized from methanol to furnish 5a 1 -a 16 . (Table 1 65 (d, 1H, C 5 -H), 8.3 (d, 1H, C 7 -H), 8.265 (d, 1H, C 8 -H), 7.4-8.2 (m, 14H, Ar-H) .
Antibacterial Activity
The synthesized compounds were tested against gram positive bacteria staphylococcus aureus and Bacillus cereus and gram negative bacteria E. coli and Pseudomonas aeruginosa and a yeast candida albicans. 3 8 9 6 6 00 >100 5a 4 9 9 6 6 00 >100 5a 5 10 8 11 6 00 >100 5a 6 8 7 8 8 00 >100 5a 7 7 7 8 8 00 >100 5a 8 6 6 6 6 00 >100 5a 9 6 6 6 6 00 >100 5a 10 8  8  8  8  00  >100  5a 11  6  9  8  8  00  >100  5a 12  7  8  8  8  00  >100  5a 13  9  8  8  7  00  >100  5a 14  9  8  6  6  00  >100  5a 15  8  9  6  6  00  >100  5a 16  8  8  6  6  00  >100  5b 1  9  8  9  9  00  >100  5b 2  7  9  7  7  00  >100  5b 3  8  8  6  6  00  >100  5b 4  11  12  9  9  00  >100  5b 5  8  7  8  8  00  >100  5b 6  9  8  8  8  00  >100  5b 7  8  8  6  6  00  >100  5b 8  9  9  8  8  00  >100  5b 9  8  8  9  9  00  >100  5b 10  11  12  10  10  00  >100  5b 11  8  8  9  9  00  >100  5b 12  7  7  7  7  00  >100  5b 13  9  8  8  9 00 >100 5b 14 6 6 6 6 00 >100 5b 15 6 6 6 7 00 >100 5a 16 6 6 6 8 00 >100
The stock solutions of compounds were prepared at a concentration of 5mg/ml & from stock solution the disc were prepared at a concentration of 100µg/ml. The testing was done on muller hinton agar plates by swabbing the agar plates with respective cultures, and placing the disc on it and incubating at 37˚C for 24 hrs. the above results were obtained.
The compounds were also tested against mycobacterium tuberculosis at a concentration of 100µg/ml. The L.J. medium was prepared from dehydrated powder following the instructions given on the dehydrated medium bottle. The compound were then added into the medium in the desired concentration and then inspisated then the prepared L.J. medium was inoculated with the pure culture of mycobacterium tuberculosis and incubated at 37˚C for 7 weeks and then the results were read.
Standard drug tetracycline and Greseofulvin were also screened under similar conditions for comparison. Results are shown in Table 3 .
